Catalyst Wire Dossier Catalyst Wire Dossier

VOCABRIA

cabotegravir sodium · ViiV Healthcare Company
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for VOCABRIA, covering 2021-01-21 to 2025-10-30. Get the full timeline:

Most recent: EMA Authorised: Vocabria (cabotegavir sodium;cabotegravir) — ViiV Healthcare B.V.

See pricing